279 related articles for article (PubMed ID: 11245648)
1. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial.
Lechat P; Hulot JS; Escolano S; Mallet A; Leizorovicz A; Werhlen-Grandjean M; Pochmalicki G; Dargie H
Circulation; 2001 Mar; 103(10):1428-33. PubMed ID: 11245648
[TBL] [Abstract][Full Text] [Related]
2. Bisoprolol: a review of its use in chronic heart failure.
McGavin JK; Keating GM
Drugs; 2002; 62(18):2677-96. PubMed ID: 12466013
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS).
Lechat P; Escolano S; Golmard JL; Lardoux H; Witchitz S; Henneman JA; Maisch B; Hetzel M; Jaillon P; Boissel JP; Mallet A
Circulation; 1997 Oct; 96(7):2197-205. PubMed ID: 9337190
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
Circulation; 1994 Oct; 90(4):1765-73. PubMed ID: 7923660
[TBL] [Abstract][Full Text] [Related]
5. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
[TBL] [Abstract][Full Text] [Related]
6. Beta-blocker efficacy according to heart rate and rhythm in patients with heart failure. Commentary on the Cardiac Insufficiency Bisoprolol Study II analysis.
Lechat PP
Card Electrophysiol Rev; 2003 Sep; 7(3):233-5. PubMed ID: 14739720
[TBL] [Abstract][Full Text] [Related]
7. Predictors of medical events in patients enrolled in the cardiac insufficiency bisoprolol study (CIBIS): a study of the interactions between beta-blocker therapy and occurrence of critical events using analysis of competitive risks.
Funck-Brentano C; Lancar R; Le Heuzey JY; Lardoux H; Soubrié C; Lechat P
Am Heart J; 2000 Feb; 139(2 Pt 1):262-71. PubMed ID: 10650299
[TBL] [Abstract][Full Text] [Related]
8. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.
Domanski MJ; Krause-Steinrauf H; Massie BM; Deedwania P; Follmann D; Kovar D; Murray D; Oren R; Rosenberg Y; Young J; Zile M; Eichhorn E;
J Card Fail; 2003 Oct; 9(5):354-63. PubMed ID: 14583895
[TBL] [Abstract][Full Text] [Related]
9. Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure--insight from the Cardiac Insufficiency Bisoprolol Study in Elderly.
Stankovic I; Neskovic AN; Putnikovic B; Apostolovic S; Lainscak M; Edelmann F; Doehner W; Gelbrich G; Inkrot S; Rau T; Herrmann-Lingen C; Anker SD; Düngen HD
Int J Cardiol; 2012 Nov; 161(3):160-5. PubMed ID: 22726401
[TBL] [Abstract][Full Text] [Related]
10. A cost-minimization of heart failure therapy with bisoprolol in the French setting: an analysis from CIBIS trial data. Cardiac Insufficiency Bisoprolol Study.
Levy P; Lechat P; Leizorovicz A; Levy E
Cardiovasc Drugs Ther; 1998 Jul; 12(3):301-5. PubMed ID: 9784910
[TBL] [Abstract][Full Text] [Related]
11. Design of the cardiac insufficiency bisoprolol study II (CIBIS II). The CIBIS II Scientific Committee.
Fundam Clin Pharmacol; 1997; 11(2):138-42. PubMed ID: 9107560
[TBL] [Abstract][Full Text] [Related]
12. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
Wikstrand J; Wedel H; Castagno D; McMurray JJ
J Intern Med; 2014 Feb; 275(2):134-43. PubMed ID: 24118421
[TBL] [Abstract][Full Text] [Related]
13. Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis.
Mulder BA; Damman K; Van Veldhuisen DJ; Van Gelder IC; Rienstra M
Clin Cardiol; 2017 Sep; 40(9):740-745. PubMed ID: 28513877
[TBL] [Abstract][Full Text] [Related]
14. Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies--CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study.
Leizorovicz A; Lechat P; Cucherat M; Bugnard F
Am Heart J; 2002 Feb; 143(2):301-7. PubMed ID: 11835035
[TBL] [Abstract][Full Text] [Related]
15. Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III Trial.
Dobre D; van Veldhuisen DJ; Goulder MA; Krum H; Willenheimer R
Cardiovasc Drugs Ther; 2008 Oct; 22(5):399-405. PubMed ID: 18528751
[TBL] [Abstract][Full Text] [Related]
16. [Clinical, hemodynamic and neurohumoral effects of long-term therapy of patients with severe chronic heart failure with beta-adrenoblocker bisoprolol].
Belenkov IuN; Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Narusov OIu; Baklanova NA; Masenko VP
Kardiologiia; 2003; 43(10):10-21. PubMed ID: 14593351
[TBL] [Abstract][Full Text] [Related]
17. Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.
Erdmann E; Lechat P; Verkenne P; Wiemann H
Eur J Heart Fail; 2001 Aug; 3(4):469-79. PubMed ID: 11511434
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II).
Simon T; Mary-Krause M; Funck-Brentano C; Jaillon P
Circulation; 2001 Jan; 103(3):375-80. PubMed ID: 11157688
[TBL] [Abstract][Full Text] [Related]
19. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.
Lancet; 1999 Jan; 353(9146):9-13. PubMed ID: 10023943
[TBL] [Abstract][Full Text] [Related]
20. Reduced costs with bisoprolol treatment for heart failure: an economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II).
Eur Heart J; 2001 Jun; 22(12):1021-31. PubMed ID: 11428837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
